Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
Zhang, Li, Prof, Ma, Shenglin, MD, Song, Xiangqun, MSc, Han, Baohui, MD, Cheng, Ying, MSc, Huang, Cheng, MD, Yang, Shujun, MD, Liu, Xiaoqing, MD, Liu, Yunpeng, MD, Lu, Shun, MD, Wang, Jie, MD, Zhang, Shucai, MD, Zhou, Caicun, MD, Zhang, Xiangwei, MD, Hayashi, Nobuya, BA, Wang, Mengzhao, MD
Published in The lancet oncology (01.05.2012)
Published in The lancet oncology (01.05.2012)
Get full text
Journal Article